Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC.
Name:
PIIS0167814018310636.pdf
Size:
841.2Kb
Format:
PDF
Description:
Full text, Open Access article
Authors
Haslett, KateBlackhall, Fiona H
Koh, P
Ashcroft, Linda
Asselin, Marie-Claude
Harris, Catherine
Jackson, A
Manoharan, Prakash
Mullan, Damian
Ryder, W David J
Taylor, Benjamin
Faivre-Finn, Corinne
Affiliation
University of Manchester, Institute of Population Health, Manchester, United KingdomIssue Date
2018